Heron Therapeuti Stock Debt To Equity

HRTX Stock

USD 1.69 0.07 3.98%

Heron Therapeuti fundamentals help investors to digest information that contributes to Heron Therapeuti's financial success or failures. It also enables traders to predict the movement of Heron Stock. The fundamental analysis module provides a way to measure Heron Therapeuti's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Heron Therapeuti stock.

		Last Reported	Projected for Next Year
	Debt To Equity	(5.20)	(4.94)

Debt To Equity is likely to rise to -4.94 in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Heron Therapeuti Company Debt To Equity Analysis

Heron Therapeuti's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.

D/E

Total Debt

Total Equity

More About Debt To Equity | All Equity Analysis

Current Heron Therapeuti Debt To Equity

6.64 %

Most of Heron Therapeuti's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Heron Therapeuti is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Heron Debt To Equity Driver Correlations

Understanding the fundamental principles of building solid financial models for Heron Therapeuti is extremely important. It helps to project a fair market value of Heron Stock properly, considering its historical fundamentals such as Debt To Equity. Since Heron Therapeuti's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Heron Therapeuti's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Heron Therapeuti's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Accounts Payable	Common Stock	Short Term Investments	Property Plant Equipment	Current Deferred Revenue	Net Tangible Assets	Capital Surpluse	Short Long Term Debt	Long Term Debt Total	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.78	0.07	-0.65	0.78	0.5	1.0	0.41	0.35	-0.06	0.88	0.6	0.7	0.82	0.76	0.31	0.83	0.85	0.85	0.27
Total Stockholder Equity	0.78		-0.51	-0.04	0.29	-0.15	0.83	0.28	0.34	-0.19	0.87	-0.01	0.22	0.99	0.2	0.09	0.4	0.9	0.9	-0.31
Net Debt	0.07	-0.51		-0.7	0.51	0.81	0.0	-0.26	-0.2	0.27	-0.05	0.75	0.49	-0.44	0.61	-0.07	0.34	-0.16	-0.16	0.83
Retained Earnings	-0.65	-0.04	-0.7		-0.88	-0.97	-0.58	-0.29	-0.06	-0.15	-0.34	-0.98	-0.83	-0.12	-0.98	-0.34	-0.85	-0.24	-0.24	-0.84
Net Receivables	0.78	0.29	0.51	-0.88		0.83	0.75	0.44	0.39	0.13	0.55	0.83	0.89	0.38	0.92	0.49	0.91	0.45	0.46	0.66
Total Liab	0.5	-0.15	0.81	-0.97	0.83		0.43	0.25	0.08	0.17	0.2	0.96	0.8	-0.07	0.93	0.37	0.76	0.1	0.1	0.86
Total Current Assets	1.0	0.83	0.0	-0.58	0.75	0.43		0.42	0.4	-0.08	0.91	0.53	0.66	0.87	0.7	0.32	0.8	0.88	0.88	0.2
Short Term Debt	0.41	0.28	-0.26	-0.29	0.44	0.25	0.42		0.62	-0.14	0.13	0.15	0.48	0.29	0.32	0.95	0.58	0.1	0.1	0.04
Accounts Payable	0.35	0.34	-0.2	-0.06	0.39	0.08	0.4	0.62		-0.2	0.33	-0.08	0.3	0.34	0.1	0.66	0.36	0.26	0.27	-0.2
Common Stock	-0.06	-0.19	0.27	-0.15	0.13	0.17	-0.08	-0.14	-0.2		-0.11	0.19	0.22	-0.16	0.12	-0.06	0.07	-0.08	-0.07	0.27
Short Term Investments	0.88	0.87	-0.05	-0.34	0.55	0.2	0.91	0.13	0.33	-0.11		0.3	0.46	0.9	0.48	0.02	0.56	0.96	0.97	0.03
Property Plant Equipment	0.6	-0.01	0.75	-0.98	0.83	0.96	0.53	0.15	-0.08	0.19	0.3		0.79	0.07	0.96	0.22	0.78	0.24	0.24	0.85
Current Deferred Revenue	0.7	0.22	0.49	-0.83	0.89	0.8	0.66	0.48	0.3	0.22	0.46	0.79		0.29	0.86	0.52	0.87	0.41	0.41	0.61
Net Tangible Assets	0.82	0.99	-0.44	-0.12	0.38	-0.07	0.87	0.29	0.34	-0.16	0.9	0.07	0.29		0.28	0.11	0.46	0.92	0.92	-0.22
Capital Surpluse	0.76	0.2	0.61	-0.98	0.92	0.93	0.7	0.32	0.1	0.12	0.48	0.96	0.86	0.28		0.35	0.88	0.4	0.4	0.77
Short Long Term Debt	0.31	0.09	-0.07	-0.34	0.49	0.37	0.32	0.95	0.66	-0.06	0.02	0.22	0.52	0.11	0.35		0.57	-0.02	-0.02	0.16
Long Term Debt Total	0.83	0.4	0.34	-0.85	0.91	0.76	0.8	0.58	0.36	0.07	0.56	0.78	0.87	0.46	0.88	0.57		0.47	0.47	0.62
Net Invested Capital	0.85	0.9	-0.16	-0.24	0.45	0.1	0.88	0.1	0.26	-0.08	0.96	0.24	0.41	0.92	0.4	-0.02	0.47		1.0	-0.11
Net Working Capital	0.85	0.9	-0.16	-0.24	0.46	0.1	0.88	0.1	0.27	-0.07	0.97	0.24	0.41	0.92	0.4	-0.02	0.47	1.0		-0.1
Capital Stock	0.27	-0.31	0.83	-0.84	0.66	0.86	0.2	0.04	-0.2	0.27	0.03	0.85	0.61	-0.22	0.77	0.16	0.62	-0.11	-0.1

Click cells to compare fundamentals

High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.

Competition

Predict Heron Therapeuti

Debt To Equity Over Time

Heron Total Stockholder Equity

Total Stockholder Equity

(32.27 Million)

Heron Therapeuti reported Total Stockholder Equity of (33.97 Million) in 2023

According to the company disclosure, Heron Therapeuti has a Debt To Equity of 6.636%. This is 87.61% lower than that of the Biotechnology sector and 65.72% lower than that of the Health Care industry. The debt to equity for all United States stocks is 86.37% higher than that of the company.

Heron Debt To Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Heron Therapeuti's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Heron Therapeuti could also be used in its relative valuation, which is a method of valuing Heron Therapeuti by comparing valuation metrics of similar companies.

Heron Therapeuti is currently under evaluation in debt to equity category among its peers.

Heron Fundamentals

	Return On Equity	-24.09
	Return On Asset	-0.0231
	Profit Margin	(0.20) %
	Operating Margin	(0.14) %
	Current Valuation	373.52 M
	Shares Outstanding	152.1 M
	Shares Owned By Insiders	0.71 %
	Shares Owned By Institutions	81.56 %
	Number Of Shares Shorted	27.91 M
	Price To Earning	(5.15) X
	Price To Book	12.60 X
	Price To Sales	1.94 X
	Revenue	127.04 M
	Gross Profit	(50.51 M)
	EBITDA	(103.79 M)
	Net Income	(110.56 M)
	Cash And Equivalents	83.54 M
	Cash Per Share	0.81 X
	Total Debt	179.63 M
	Debt To Equity	6.64 %
	Current Ratio	1.77 X
	Book Value Per Share	(0.26) X
	Cash Flow From Operations	(58.79 M)
	Short Ratio	14.20 X
	Earnings Per Share	(0.16) X
	Price To Earnings To Growth	(0.18) X
	Target Price	6.0
	Number Of Employees	126
	Beta	1.81
	Market Capitalization	267.69 M
	Total Asset	222.51 M
	Retained Earnings	(1.91 B)
	Working Capital	109.09 M
	Current Asset	134.75 M
	Current Liabilities	19.73 M
	Net Asset	222.51 M

About Heron Therapeuti Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Heron Therapeuti's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Heron Therapeuti using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Heron Therapeuti based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for Heron Stock Analysis

When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC